2021-00894. Notice of Meetings  

  • Start Preamble

    AGENCY:

    Agency for Healthcare Research and Quality (AHRQ), HHS.

    ACTION:

    Notice of five AHRQ Subcommittee meetings.

    SUMMARY:

    The subcommittees listed below are part of AHRQ's Health Services Research Initial Review Group Committee. Grant applications are to be reviewed and discussed at these meetings. Each subcommittee meeting will be closed to the public.

    DATES:

    See below for dates of meetings:

    1. Healthcare Safety and Quality Improvement Research (HSQR)

    Date: February 3-4, 2021

    2. Healthcare Effectiveness and Outcomes Research (HEOR)

    Date: February 10-11, 2021

    3. Health System and Value Research (HSVR)

    Date: February 11-12, 2021

    4. Health Care Research and Training (HCRT)

    Date: February 25-26, 2021 & March 1-2, 2021

    5. Healthcare Information Technology Research (HITR)

    Date: February 25-26, 2021

    ADDRESSES:

    Agency for Healthcare Research and Quality (Virtual Review), 5600 Fishers Lane, Rockville, Maryland 20857.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    (to obtain a roster of members, agenda or minutes of the non-confidential portions of the meetings.)

    Jenny Griffith, Committee Management Officer, Office of Extramural Research Education and Priority Populations, Agency for Healthcare Research and Quality (AHRQ), 5600 Fishers Lane, Rockville, Maryland 20857, Telephone (301) 427-1557.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In accordance with section 10 (a)(2) of the Federal Advisory Committee Act (5 U.S.C. App. 2), AHRQ announces meetings of the above-listed scientific peer review groups, which are subcommittees of AHRQ's Health Services Research Initial Review Group Committee. The subcommittee meetings will be closed to the public in accordance with the provisions set forth in 5 U.S.C. App. 2 section 10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Agenda items for these meetings are subject to change as priorities dictate.

    Start Signature

    Dated: January 12, 2021.

    Marquita Cullom,

    Associate Director.

    End Signature End Supplemental Information

    [FR Doc. 2021-00894 Filed 1-14-21; 8:45 am]

    BILLING CODE 4160-90-P